|
Volumn 46, Issue 6, 2014, Pages 1898-1899
|
What defines success in pancreas and islet transplantation - Insulin independence or prevention of hypoglycemia? A review
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONFERENCE PAPER;
GLUCOSE BLOOD LEVEL;
GRAFT FAILURE;
GRAFT SURVIVAL;
HUMAN;
HYPOGLYCEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN DEPENDENCE;
INSULIN INDEPENDENCE;
PANCREAS DISEASE;
PANCREAS ISLET TRANSPLANTATION;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
SURGICAL RISK;
SURVIVAL RATE;
ARTICLE;
DIABETIC PATIENT;
FASTING BLOOD GLUCOSE;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RESPONSE;
INSULIN TREATMENT;
ORGAN DONOR;
SURGICAL MORTALITY;
COMORBIDITY;
DIABETES MELLITUS, TYPE 1;
MALE;
PROCEDURES;
RISK ASSESSMENT;
TREATMENT OUTCOME;
C PEPTIDE;
GLUCOSE;
HEMOGLOBIN;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
ANTIDIABETIC AGENT;
COMORBIDITY;
DIABETES MELLITUS, TYPE 1;
HUMANS;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
INSULIN;
ISLETS OF LANGERHANS TRANSPLANTATION;
MALE;
PANCREAS TRANSPLANTATION;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
EID: 84906084411
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2014.06.004 Document Type: Conference Paper |
Times cited : (12)
|
References (4)
|